CLINICAL_TRIALS
research
· 2026-03-19
Clinical Trial Update: Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. [NA]
Summary
A non-inferiority clinical trial compares salvage pelvic radiotherapy given in 25 fractions (62.5 Gy) versus 20 fractions (52.5 Gy) for recurrent prostate cance…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: CHU de Quebec-Universite Laval | Conditions: Reccurent/Metastatic Solid Tumor Disease, Prostate Cancer (Post Prostatectomy) | NA | Status: NOT_YET_RECRUITING